Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CPT2 | P23786 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 3/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3713463 | 1.00 | CYP2C19 (0.50) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL4628158 | 1.00 | CYP2C19 (0.50) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL28838440 | 0.83 | CYP2D6 (0.36) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL13688692 | 0.83 | HMGCR (0.44) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL11180724 | 0.81 | HMGCR (0.42) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL19031719 | 0.78 | CYP2C19 (0.48) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL18138374 | 0.78 | CYP2C19 (0.43) | CYP2C19HIF1ATSHRCYP2D6HMGCR | |
| SCHEMBL823261 | 0.77 | — | — | |
| SCHEMBL535726 | 0.77 | — | — | |
| SCHEMBL7200959 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3724307-B1 | LAUNDRY SURFACTANTS HAVING INHERENT BUILDING CAPACITY DERIVED FROM BIO-BASED HYDROYACIDS AND EPOXIDES; AND PROCESS THEREFORE | BATTELLE MEMORIAL INSTITUTE (US) | 2025-07-16 | — | — | EP | claimed |
| EP-2734509-B1 | METHODS FOR PREPARATION OF AMMONIUM SALTS OF C4 DIACIDS BY FERMENTATION AND INTEGRATED METHODS FOR MAKING C4 DERIVATIVES THEREOF | ARCHER DANIELS MIDLAND CO (US) | 2018-12-26 | — | — | EP | claimed |
| WO-2011119637-A9 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2015-12-10 | — | — | WO | claimed |
| US-20140343039-A1 | PROCESS FOR PREPARING CEPHALOTAXINE ESTERS | ROBIN JEAN-PIERRE (CH) | 2014-11-20 | — | — | US | claimed |
| EP-2550365-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | Stemina Biomarker Discovery, Inc. (US) | 2013-01-30 | — | — | EP | claimed |
| US-20120022250-A1 | PROCESS FOR PREPARING CEPHALOTAXINE ESTERS | ROBIN JEAN-PIERRE (CH) | 2012-01-26 | — | — | US | claimed |
| WO-2011119637-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2011-09-29 | — | — | WO | claimed |
| WO-2010103405-A2 | PROCESS FOR PREPARING CEPHALOTAXINE ESTERS | ROBIN JEAN-PIERRE (CH) | 2010-09-16 | — | — | WO | claimed |
| EP-1282680-A1 | COMPOSITIONS COMPRISING CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-12 | — | — | EP | claimed |
| US-6503413-B2 | Polyalkylene polysiloxane, buffering agent, aqueous carrier | THE PROCTER & GAMBLE COMPANY | 2003-01-07 | — | — | US | claimed |
| US-20020010154-A1 | Compositions comprising cyclodextrin | THE PROCTER & GAMBLE COMPANY | 2002-01-24 | — | — | US | claimed |
| WO-2001088076-A1 | COMPOSITIONS COMPRISING CYCLODEXTRIN | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-22 | — | — | WO | claimed |
| US-6289286-B1 | Surface regeneration of biosensors and characterization of biomolecules associated therewith | BIACORE AB (SE) | 2001-09-11 | — | — | US | claimed |
| WO-2001060961-A1 | STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| EP-1082607-A1 | SURFACE REGENERATION OF BIOSENSORS | Biacore AB (SE) | 2001-03-14 | — | — | EP | claimed |
| EP-0983224-A1 | PROCESS FOR PREPARING AND PURIFYING COMPLEX ESTERS | Neste Chemicals Oy (FI) | 2000-03-08 | — | — | EP | claimed |
| WO-1999063333-A1 | SURFACE REGENERATION OF BIOSENSORS | BIACORE AB (SE) | 1999-12-09 | — | — | WO | claimed |
| WO-1998050338-A1 | PROCESS FOR PREPARING AND PURIFYING COMPLEX ESTERS | NESTE CHEMICALS OY (FI) | 1998-11-12 | — | — | WO | claimed |
| US-4361471-A | Electrolytic swimming pool chlorination | WALKER & BRUNSON INCORPORATED, A CORP. OF HOUSTON, TX. | 1982-11-30 | — | — | US | claimed |
| US-4285841-A | Highly concentrated fatty acid containing liquid detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1981-08-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010154-A1 | Compositions comprising cyclodextrin | FFAR4, FRG1, FGB | CYP2C19 945/4885HIF1A 4348/4885TSHR 3607/4885 |
| US-20120022250-A1 | PROCESS FOR PREPARING CEPHALOTAXINE ESTERS | CHRM1, OPRM1, CHRM2 | CYP2C19 1432/4885HIF1A 1107/4885TSHR 561/4885 |
| US-20140343039-A1 | PROCESS FOR PREPARING CEPHALOTAXINE ESTERS | CFH, C5, CHRM1 | CYP2C19 414/4885HIF1A 1226/4885TSHR 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.